Tocqueville Asset Management L.P. Lexicon Pharmaceuticals, Inc. Transaction History

Tocqueville Asset Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$10.32 - $13.06 $140,868 - $178,269	-13,650 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$7.8 - $13.69 $106,470 - $186,868	13,650 New	13,650 $164,000
Q1 2018 May 14, 2018	SELL	$7.86 - $11.39 $107,682 - $156,043	-13,700 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$8.77 - $12.28 $1.06 Million - $1.49 Million	-121,300 Reduced 89.85%	13,700 $135,000
Q3 2017 Oct 30, 2017	BUY	$12.17 - $16.3 $1.64 Million - $2.2 Million	135,000	135,000 $1.66 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.